Robertson et al (1996) reported that DES inhibits proliferation of androgen-dependent and androgen-independent human prostate cancer cell lines by promoting cell cycle arrest, inducing apoptosis through a mechanism not mediated by estrogen receptors. The gene discussed is ESR1; the disease is prostate cancer.